DOCUSATE SODIUM- docusate sodium capsule, liquid filled
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
citric acid anhydrous, FD&C red #40, FD&C yellow #6, gelatin, glycerin, polyethylene glycol, propylene glycol, purified water, sorbitol special, and white edible ink
Manufactured by:
Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.
Wuhan, Hubei 430206,
China
Docusate Sodium Capsules
250 mg
NDC 53345-035-01
7000 Capsules
IMPORTANT:
1.Inspect immediately upon receipt.
2.This is a bulk shipment, intended for further processing only.
3.Protect from heat, humidity, and light. Do not refrigerate.
4.Store at 15-30°C (59-86°F)
CAUTION : "FOR FURTHER MANUFACTURING, PROCESSING OR REPACKING"
DOCUSATE SODIUM
docusate sodium capsule, liquid filled |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Labeler - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd (421293287) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd | 421293287 | manufacture(53345-035) , analysis(53345-035) |